Holen Sie sich die Stockscreener-App
26.74
1.40%
-0.38
Handel nachbörslich:
26.74
Finanzdaten der Forte Biosciences Inc-Aktie (FBRX)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | 1.314 | - |
| Operating Expenses |
58.76%
18.38
|
11.58 | 16.12 | 7.351 | 8.629 |
| Operating Income/Loss |
58.76%
-18.38
|
-11.58 | -16.12 | -7.351 | -8.629 |
| Income/Loss From Continuing Operations Before Tax |
57.19%
-17.68
|
-11.25 | -15.66 | -7.155 | -8.392 |
| Income/Loss From Continuing Operations After Tax |
57.19%
-17.68
|
-11.25 | -15.66 | -7.155 | -8.392 |
Net Income/Loss
|
57.19%
-17.68
|
-11.25 | -15.66 | -7.155 | -8.392 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Earnings Per Share |
3.13%
-0.99
|
-0.96 | -1.37 | 3.18 | -4.54 |
| Diluted Earnings Per Share |
3.13%
-0.99
|
-0.96 | -1.37 | 3.18 | -4.54 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.48%
1.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):